Publicacións nas que colabora con Francisca Lago Paz (93)

2023

  1. Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients

    Transplantation, Vol. 107, Núm. 2, pp. 466-474

  2. Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients

    Transplantation, Vol. 107, Núm. 9, pp. 2064-2072

  3. Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  4. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

    Biomedicine and Pharmacotherapy, Vol. 161

2022

  1. Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients

    Journal of Heart and Lung Transplantation, Vol. 41, Núm. 2, pp. 137-147

  2. Leptin in Osteoarthritis and Rheumatoid Arthritis: Player or Bystander?

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  3. Progranulin in Musculoskeletal Inflammatory and Degenerative Disorders, Focus on Rheumatoid Arthritis, Lupus and Intervertebral Disc Disease: A Systematic Review

    Pharmaceuticals, Vol. 15, Núm. 12

  4. Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases

    Journal of Personalized Medicine, Vol. 12, Núm. 7

  5. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

    Scientific Reports, Vol. 12, Núm. 1

  6. Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  7. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

  8. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes

    Laboratory Investigation, Vol. 102, Núm. 9, pp. 989-999

2021

  1. Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes

    Laboratory Investigation, Vol. 101, Núm. 12, pp. 1550-1560

  2. Relaxin has beneficial effects on liver lipidome and metabolic enzymes

    FASEB Journal, Vol. 35, Núm. 7

2020

  1. Adipokines and inflammation: Focus on cardiovascular diseases

    International Journal of Molecular Sciences, Vol. 21, Núm. 20, pp. 1-34

  2. Levels of the novel endogenous antagonist of ghrelin receptor, liver-enriched antimicrobial peptide-2, in patients with rheumatoid arthritis

    Nutrients, Vol. 12, Núm. 4

2019

  1. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases

    Biochemical Pharmacology, Vol. 165, pp. 196-206

  2. Circulating Sphingosine-1-Phosphate as A Non-Invasive Biomarker of Heart Transplant Rejection

    Scientific reports, Vol. 9, Núm. 1, pp. 13880

  3. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

  4. Molecular relationships among obesity, inflammation and intervertebral disc degeneration: Are adipokines the common link?

    International Journal of Molecular Sciences, Vol. 20, Núm. 8